Avacta Group Plc - notizie pubblicate 142 - letture 4.949
AVACTA GROUP PLC
Avacta Announces the Appointment of Darlene Deptula Hicks as Non Executive Director of the Board of Directors
London, england; july 8, 2024; avacta group plc (aim: avct), a life sciences company developing innovative, targeted cancer treatments and powerful diagnostics, today announced the ...
AVACTA GROUP PLC
AGM Business Update deck
Annual general meeting of shareholders avacta group plc june 2024 avacta is evolving in response to recent success: we have a singular focus on delivery of novel therapeutics with ...
AVACTA GROUP PLC
Result of AGM
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer avacta group plc published this conten ...
AVACTA GROUP PLC
Result of Annual General Meeting
Avacta group plc (aim: avct), a life sciences company developing innovative, targeted cancer treatments and powerful diagnostics, is pleased to announce that all resolutions have b ...
AVACTA GROUP PLC
AGM Busness Update
Second cohort in the ava6000 phase 1 arm 2 completed, patient dosing is ongoing in cohort three avacta announces the assembly of a scientific advisory board to guide ava6000 develo ...
AVACTA GROUP PLC
AGM Business Update
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer avacta group plc published this conten ...
AVACTA GROUP PLC
Shaun Chilton appointed Non-Executive Chairman
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer avacta group plc published this conten ...
AVACTA GROUP PLC
Shaun Chilton is appointed Non-Executive Chairman of the Avacta Board of Directors
Avacta group plc (aim: avct), a life sciences company developing innovative, targeted cancer treatments and powerful diagnostics, announces that shaun chilton has been appointed no ...
AVACTA GROUP PLC
Appointment of Nominated Adviser and Sole Broker
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer avacta group plc published this conten ...
AVACTA GROUP PLC
Appointment of Nominated Adviser and Sole Broker
Avacta group plc (aim: avct), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today announces the appointment of peel hunt llp as i ...
AVACTA GROUP PLC
Targeting the Tumor Microenvironment – June 2024 presentation deck
Targeting the tumor microenvironment avacta therapeutics june 2024 avacta is challenging the current drug delivery models to expand the reach of highly potent therapeutics using pe ...
AVACTA GROUP PLC
Posting of Annual Report and Notice of AGM
Avacta group plc (aim: avct), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today announces that its annual report and accounts f ...
AVACTA GROUP PLC
Annual Report and Accounts 2023
Avacta report and accounts 2023 contents 2 highlights 6 pre|cisiontm technology 8 affimer® technology 10 investment proposition strategic report chairman's statement chief executi ...
AVACTA GROUP PLC
AGM Notice – 2024
Notice of annual general meeting avacta group plc (incorporated in england and wales with registered number 04748597) notice is given that the annual general meeting of avacta grou ...
AVACTA GROUP PLC
Successful Completion of First Cohort and Dosing of Three Patients of the Second Cohort in Arm 2 of Avacta’s AVA6000 Phase 1 trial
Initiation of fapi-pet sub-study in the ava6000 phase 1 trial first cohort successfully completed in arm 2 with no adverse safety signals and initiation of fapi-pet sub-study to be ...
Per i consulenti finanziari
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti